IEFQ:LSE:LSE-iShares Edge MSCIope Quality Factor UCITS (GBX)

ETF | Others |

Last Closing

USD 864.75

Change

+8.25 (+0.96)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+2.77 (+2.10%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.14 (+0.99%)

USD 581.04B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.22 (+1.26%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.20 (+0.32%)

USD 266.08B
0QZO:LSE 0QZO

+0.40 (+0.37%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.37 (+1.30%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

+2.77 (+1.73%)

USD 202.26B
0R24:LSE Intel Corp.

+0.46 (+2.42%)

USD 196.14B

ETFs Containing IEFQ:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.72% 73% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.72% 73% C 71% C-
Trailing 12 Months  
Capital Gain 6.20% 37% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.20% 34% F 45% F
Trailing 5 Years  
Capital Gain 32.22% 58% F 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.22% 56% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 9.52% 60% D- 65% D
Dividend Return 9.52% 59% D- 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.69% 65% D 79% B-
Risk Adjusted Return 89.11% 84% B 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike